Primary hyperoxaluria - The German experience

American Journal of Nephrology

Volumn 25, Issue 3, 2005, Pages 276-281

  Hoppe, Bernd ^a,e   Latta, Kay ^b   Von Schnakenburg, Christian ^c   Kemper, Markus J ^d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Clementine Kinderhospital   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Oxalate; Primary hyperoxaluria, diagnosis; Primary hyperoxaluria, epidemiology; Primary hyperoxaluria, treatment and outcome

Indexed keywords

CITRIC ACID; MAGNESIUM; OXALIC ACID; PYRIDOXINE;

CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE CLASSIFICATION; ENZYME ACTIVITY; FLUID THERAPY; GENOTYPE PHENOTYPE CORRELATION; HEALTH SURVEY; HEMATURIA; HEMODIALYSIS; HUMAN; INFORMATION PROCESSING; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER GRAFT; MUTATIONAL ANALYSIS; OXALOSIS 1; PRIORITY JOURNAL; SAMPLE SIZE; URINALYSIS; URINARY TRACT INFECTION; UROLITHIASIS;

CITRIC ACID; FLUID THERAPY; GERMANY; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAGNESIUM; NEPHROLOGY; PEDIATRICS; PREVALENCE; PYRIDOXINE; RENAL DIALYSIS; TIME FACTORS;

EID: 23944468032     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086358     Document Type: Conference Paper

References (20)

1. Leumann E, Hoppe B: The primary hyperoxalurias. J Am Soc Nephrol 2001;12:1986-1993.
2. Von Schnakenburg C, Latta K: Hyperoxaluria; in Blau N, Duran M, Blaskovics ME, Gibson KM (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, ed 2. Berlin, Springer. 2002. pp 505-518.
3. Latta K, Brodehl J: Primary hyperoxaluria type I. Eur J Pediatr 1990;149:518-522.
4. Danpure CJ: Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 2004;98:e39-e44.
5. Rumsby G, Williams E, Coulter-Mackie M: Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 2004;66:959-963.
6. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP: The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 1999;8:2063-2069.
7. Kemper MJ, Conrad S, Müller-Wiefel DE: Primary hyperoxaluria type 2. Eur J Pediatr 1997;156:509-512.
8. Van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR: Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004;66:746-752.
9. 6) dose response and G630A genotyping in type I primary hyperoxaluria (abstract). J Am Soc Nephrol 2004;15:P428A, SA-PO573.
10. Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehl J: Oxalic acid elimination in children with chronic renal failure: comparison between hemodialysis and peritoneal dialysis. Pediatr Nephrol 1996;10:488-492.
11. Jamieson NV on behalf of the European PH I Transplantation Study Group: The European primary hyperoxaluria type 1 transplant registry report on the results of combined liver/kidney transplantation for primary hyperoxaluria 1984-1994. Nephrol Dial Transplant 1995;10(suppl 8):33-37.
12. Hoppe B, Langman CB: A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003;18:986-991.
13. Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A: Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 2003;8:e437-443.
14. Danpure CJ, Jennings PR, Watts RWE: Enzymological diagnosis of primary hyperoxaluria type I by measurement of hepatic alanine:glyoxylate aminotransferase. Lancet 1987;8528:289-291.
15. Kopp N, Leumann E: Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995;10:2224-2227.
16. Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N: Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 1995;10(suppl 8):3-7.
17. Van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA: Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003;18:273-279.
18. Amoroso A, Pirulli D, Florian F, Puzzer D, Boniotto M, Crovella S, Zezlina S, Spano A, Mazzola G, Savoldi S, Ferrettini C, Berutti S, Petrarulo M, Marangella M: AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 2001;12:2072-2079.
19. Leumann E, Hoppe B: Pre-emptive liver transplantation in primary hyperoxaluria type 1: a controversial issue. Pediatr Transplant 2000;4:161-164.
20. Hoppe B, Gatter N, Beck BB, von Unruh G, Laube N, Hesse A, Sidhu H: Oral administration of Oxalobacter formigenes capsules is effective in lowering the urinary oxalate excretion in patients with primary hyperoxaluria type I (PH I). J Am Soc Nephrol 2004;15:SU-FC056, P55A.